- Home
- NSPR vs SWZ Comparison
NSPR vs SWZ Comparison
Compare NSPR & SWZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- SWZ
- Stock Information
- Founded
- NSPR 2005
- SWZ 1986
- Country
- NSPR United States
- SWZ United States
- Employees
- NSPR N/A
- SWZ N/A
- Industry
- NSPR Medical/Dental Instruments
- SWZ Finance Companies
- Sector
- NSPR Health Care
- SWZ Finance
- Exchange
- NSPR Nasdaq
- SWZ Nasdaq
- Market Cap
- NSPR 75.1M
- SWZ 82.2M
- IPO Year
- NSPR N/A
- SWZ N/A
- Fundamental
- Price
- NSPR $2.44
- SWZ $6.26
- Analyst Decision
- NSPR Strong Buy
- SWZ
- Analyst Count
- NSPR 2
- SWZ 0
- Target Price
- NSPR $4.50
- SWZ N/A
- AVG Volume (30 Days)
- NSPR 44.5K
- SWZ 14.2K
- Earning Date
- NSPR 08-05-2025
- SWZ 01-01-0001
- Dividend Yield
- NSPR N/A
- SWZ 6.59%
- EPS Growth
- NSPR N/A
- SWZ N/A
- EPS
- NSPR N/A
- SWZ N/A
- Revenue
- NSPR $7,027,000.00
- SWZ N/A
- Revenue This Year
- NSPR $27.41
- SWZ N/A
- Revenue Next Year
- NSPR $127.08
- SWZ N/A
- P/E Ratio
- NSPR N/A
- SWZ N/A
- Revenue Growth
- NSPR 8.49
- SWZ N/A
- 52 Week Low
- NSPR $2.07
- SWZ $7.12
- 52 Week High
- NSPR $3.80
- SWZ $8.57
- Technical
- Relative Strength Index (RSI)
- NSPR 50.84
- SWZ 38.88
- Support Level
- NSPR $2.40
- SWZ $6.25
- Resistance Level
- NSPR $2.59
- SWZ $6.37
- Average True Range (ATR)
- NSPR 0.11
- SWZ 0.06
- MACD
- NSPR 0.00
- SWZ 0.03
- Stochastic Oscillator
- NSPR 57.50
- SWZ 8.75
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.